beta1-adrenoceptor-targeted imaging agents (Lantheus)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namebeta1-adrenoceptor-targeted imaging agents (Lantheus)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Radioactive diagnostic agentDiagnostic agent (In vivo)
Mechanisms of ActionBeta-1 adrenergic receptor modulators
TargetsBeta-1 adrenergic receptor
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLantheus Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLantheus Holdings Inc
Active IndicationsN/A
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A